Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers
Arvind Arora(Himalayan Institute Hospital Trust), Srinivasan Madhusudan(Nottingham University Hospitals NHS Trust), Deborah L. Croteau(National Institutes of Health), Emad A. Rakha(Nottingham University Hospitals NHS Trust), Rachel Doherty(University of Nottingham), Paul M. Moseley(Nottingham University Hospitals NHS Trust), Stephen Chan(Heidelberg University), Helen E. Bryant(University of South Alabama), K. Patterson(University of Sheffield), Ian O. Ellis(University of Nottingham), Devika Agarwal(University of Oxford), Vilhelm A. Bohr(University of Copenhagen), Andrew R. Green(Nottingham Biomedical Research Centre), Khalid Hameed(Nottingham University Hospitals NHS Trust), Mohammed A. Aleskandarany(Nottingham University Hospitals NHS Trust), Tarek M. Abdel-Fatah(Nottingham University Hospitals NHS Trust), Graham Ball(Computer Algorithms for Medicine)
Cited by 34
Related Papers
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
|New England Journal of Medicine|2010|4.5k
The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes
|Nature Communications|2016|1.8k
Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease
|Nature Neuroscience|2019|1.7k
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k
The Attractive Female Body Weight and Female Body Dissatisfaction in 26 Countries Across 10 World Regions: Results of the International Body Project I
|Personality and Social Psychology Bulletin|2010|718